Fake medicines – imminent risks to global health
Jamil Chade, Journalist
Mario Ottiglio, IFPMA
David Taylor, Professor of Pharmaceutical and Public Health Policy, UCL School of Pharmacy
Robert Johnstone, Board Member, IAPO
Luc Besancon, Acting General Secretary for Professional, Scientific and External affairs, International Pharmaceutical Federation
Martin Bernhardt, Vice President International Institutions, Sanofi
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
